CCL2 and type 2 diabetes mellitus: Importantly, studies have shown that reducing MCP-1 levels in mouse models of type 1 and type 2 diabetes mellitus can inhibit macrophage infiltration, thereby alleviating proteinuria and inflammatory markers (30).